4528 — ONO PHARMACEUTICAL Share News
0.000.00%
Last trade - 00:00Table: Ono Pharm -2024/25 group forecast(IFRS)
Brief: FDA Approves Vimseltinib For Symptomatic Tenosynovial Giant Cell Tumor
Table: Ono Pharm -9-MTH group results (IFRS)
Brief: US FDA Accepts Priority Review For Deciphera's New Drug Application For Vimseltinib
Brief: Ono Pharma Chairman Says Seeking Additional Acquisition Targets In U.S. In 100 Billion Yen Range - Nikkei
Japan's Otsuka Pharma to pay up to $1.1 bln to acquire Jnana Therapeutics (updated)
Table: Ono Pharm -Q1 group results (IFRS)
Table: Ono Pharm -2023/24 group results (IFRS)
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Deciphera Pharmaceuticals To Be Acquired By ONO Pharmaceutical For $2.4 Billion
Deciphera Pharma rises as co to be acquired by ONO Pharmaceutical for $2.4 bln
Japan's Ono Pharmaceutical to buy Deciphera for $2.4 billion (updated)
Japan's ONO Pharmaceutical to buy Deciphera for $2.4 billion
Announces Completion Of 50 Billion Yen Share Buyback Plan
Brief: Ono Pharma: Entered Into Research Collaboration Agreement With Inveniai To Identify Novel Therapeutic Targets